InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Schneider Jerry A., Director. Director active across 1 company, notably Kiromic Biopharma, Inc.. Cumulatively, 1 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €30k. History available since 24 May 2021. The latest transaction was filed on 24 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Jerry A. Schneider is a Director at Kiromic Biopharma, Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Kiromic.